KRR has $4m in the kitty. When they release the SS and I am still thinking the CAPEX will be in the range of between $700 - $1 billion, which is around 60% lower than what was announced in the last SS of between $2 billion and $2.5 billion.
It was stated even with the CAPEX of $2 to $2.5 billion, they expected the projected payback period based on the analysis in the Scoping Study would be between three to four years, so you can imagine paying off the new $1 billion CAPEX much sooner!
I am looking forward to the end of this month March which is the end of (Q1) for the release of the new SS, though I don’t think it will have much impact on the current SP immediately, though it should create interest in the company again and hopefully see the SP rise slowly and increasingly towards the release of the PFS which is expected by end of July but I will say end of September which is again the end of a quarter (Q3)
From the AGM and this is how I remember it and (before anyone complains this is not word for word.) It was said that Vanadium & fluorspar was the priority and Mt Remarkable was not for now.
My comments/posts are based completely on my own experience thoughts and interpretation along with my current financial position at the time.
Conduct your own due diligence, consult a licensed financial advisor or broker before making any and all investment decisions. As usual all constructive criticism welcomed.Good luck to all that hold.
- Forums
- ASX - By Stock
- Ann: Positive VAT Leach Test Results
KRR has $4m in the kitty. When they release the SS and I am...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $13.75M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $8.83K | 735.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 174990 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1876614 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 6200311 | 0.009 |
8 | 28480304 | 0.008 |
5 | 5799516 | 0.007 |
6 | 5100808 | 0.006 |
12 | 8038888 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1100000 | 2 |
0.011 | 2390000 | 4 |
0.012 | 1242985 | 7 |
0.013 | 1846567 | 8 |
0.014 | 972413 | 7 |
Last trade - 11.28am 25/11/2024 (20 minute delay) ? |
Featured News
KRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online